Trials / Conditions / Stage IV Ovarian Germ Cell Tumor

Stage IV Ovarian Germ Cell Tumor

21 registered clinical trials studyying Stage IV Ovarian Germ Cell Tumor.

Status	Trial	Sponsor	Phase
Completed	Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritone NCT02122185	University of Chicago	Phase 2
Withdrawn	Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian NCT01927393	City of Hope Medical Center	N/A
Completed	Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot B NCT02013492	William Carson	EARLY_Phase 1
Completed	Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointe NCT01846520	City of Hope Medical Center	N/A
Terminated	Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors NCT01808534	Indiana University School of Medicine	Phase 2
Withdrawn	Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant NCT01558778	Roswell Park Cancer Institute	N/A
Terminated	Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer NCT01494012	Stanford University	Phase 1
Completed	Vaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian Cancer NCT01322802	University of Washington	Phase 1
Terminated	Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors NCT01233505	National Cancer Institute (NCI)	Phase 1
Completed	Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors NCT01155258	University of Southern California	Phase 1
Completed	Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors NCT01131234	National Cancer Institute (NCI)	Phase 1
Completed	Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) NCT01126346	Wake Forest University Health Sciences	N/A
Completed	Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritone NCT01080521	Gynecologic Oncology Group	—
Completed	Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer NCT01037790	Abramson Cancer Center at Penn Medicine	Phase 2
Completed	Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relaps NCT00957905	National Cancer Institute (NCI)	Phase 2
Completed	Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignan NCT01079832	Case Comprehensive Cancer Center	Phase 2
Completed	Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors NCT00408655	National Cancer Institute (NCI)	Phase 1
Terminated	EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer NCT00087191	National Cancer Institute (NCI)	N/A
Completed	Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Tre NCT00228358	University of Washington	Phase 1
Completed	7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid NCT00031681	National Cancer Institute (NCI)	Phase 1
Completed	Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer NCT00436254	University of Washington	Phase 1